Previous close | 22.14 |
Open | 21.00 |
Bid | 24.30 |
Ask | 27.10 |
Strike | 115.00 |
Expiry date | 2024-07-19 |
Day's range | 21.00 - 22.17 |
Contract range | N/A |
Volume | |
Open interest | 38 |
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.
Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.